Brief: Vaccinex Reports Q2 Revenue Of $25,000
14/08/2019 14:13
Aug 14 (Reuters) - Vaccinex Inc VCNX.O :
* VACCINEX REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
* CASH & CASH EQUIVALENTS AND MARKETABLE SECURITIES ON JUNE
30
WERE $5.3 MILLION
* QTRLY REVENUE $25,000 VERSUS $126,000
* Q2 REVENUE VIEW $100000.00 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX4CPBCw
Further company coverage: VCNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaccinex
See all newsBrief: Vaccinex Reports Third Quarter 2024 Financial Results And Provides Corporate Update
Brief: Vaccinex Says On Oct 7, Got Letter From The Nasdaq Listing Staff Stating That Co Had Not Regained Compliance With The Equity Standard
Brief: VaccinexExercise Of Warrants For $6.2 Million In Gross Proceeds
Brief: Vaccinex Provides Update On New Findings For Signal-Ad Phase 1B/2 Trial Of Pepinemab In Alzheimer’S Disease
Brief: Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease